Treatment guide
What Is GLP-1 Therapy?
GLP-1 receptor agonists are medications that mimic a naturally occurring hormone involved in blood sugar regulation, appetite, and digestion. Some products in this class are approved for type 2 diabetes, chronic weight management, or both, depending on the specific medication and product.
This guide is educational and does not recommend a specific medication.
What is GLP-1 therapy?
GLP-1 therapy uses medications that act on appetite, digestion, and blood sugar pathways
GLP-1 stands for glucagon-like peptide-1, a hormone involved in insulin response, appetite signaling, and slower stomach emptying. GLP-1 receptor agonist medications are designed to act on related receptors in clinically specific ways.
The phrase GLP-1 therapy is often used broadly, but products are not interchangeable. Semaglutide, liraglutide, and tirzepatide have different product names, indications, delivery forms, and safety information.
How GLP-1 medications work
They act on hormone pathways involved in appetite, digestion, and glucose regulation
GLP-1 receptor agonists mimic GLP-1 activity. Tirzepatide is related but acts on both GIP and GLP-1 receptors. These differences matter when discussing product selection, approved uses, tolerability, and access.
Common medications
Common GLP-1 and related medications are not interchangeable
Semaglutide products include Wegovy for chronic weight management and Ozempic or Rybelsus for type 2 diabetes-related indications. Tirzepatide products include Zepbound for chronic weight management and Mounjaro for type 2 diabetes. Liraglutide products include Saxenda for chronic weight management and Victoza for type 2 diabetes.
Who may discuss treatment?
Eligibility depends on diagnosis, risk factors, and clinical judgment
People may discuss GLP-1 or related medications with a clinician for type 2 diabetes, chronic weight management, or weight-related health risks when an FDA-approved product fits the diagnosis and eligibility criteria.
A clinician should review medical history, current medications, pregnancy plans, prior pancreatitis or gallbladder disease, thyroid cancer history, gastrointestinal conditions, kidney issues, and other individualized concerns.
Potential benefits
Potential benefits are tied to the specific medication and indication
Blood sugar support
Some GLP-1 and related medications are approved to improve glycemic control in people with type 2 diabetes.
Chronic weight management
Certain products are approved for chronic weight management when eligibility criteria are met and treatment is paired with lifestyle changes.
Cardiometabolic context
Some products have additional cardiovascular or kidney-related indications in specific patient populations. A clinician should explain whether those apply.
Risks and limitations
GLP-1 treatment requires safety review and ongoing follow-up
Common side effects can include nausea, vomiting, diarrhea, constipation, abdominal discomfort, and reduced appetite. Product labels also include important warnings and contraindications that should be reviewed with a clinician.
GLP-1 medications are not a substitute for medical evaluation, nutrition planning, physical activity, or follow-up. Some people are not candidates, and some stop treatment because of tolerability, access, cost, or clinical concerns.
Eligibility and evaluation
Medical evaluation should happen before medication choice
A responsible consultation should cover diagnosis, health history, contraindications, current medications, previous weight-loss attempts, nutrition, physical activity, and follow-up expectations.
Treatment and follow-up
Treatment often involves gradual changes and regular check-ins
Follow-up may address side effects, dose tolerance, medication access, nutrition, hydration, muscle preservation, lab needs, and what happens if treatment is paused or stopped.
Questions to ask
Questions to ask a GLP-1 provider
Eligibility
What diagnosis, BMI, weight-related conditions, medications, and medical history factors affect whether GLP-1 treatment is appropriate?
Medication choice
Which FDA-approved products do you prescribe, what are they approved for, and why might one fit my situation better than another?
Safety review
Which contraindications, warnings, side effects, drug interactions, and emergency symptoms should I understand before starting?
Follow-up
How often will we check symptoms, tolerability, dose changes, nutrition, muscle preservation, and long-term progress?
Costs and access
What costs are separate for visits, labs, medication, refills, prior authorization, cash-pay programs, and follow-up?
Telehealth
Which parts of care can happen virtually, and when are in-person exams, labs, or local pharmacy coordination needed?
Clinic comparison
How to choose a GLP-1 clinic
Licensed oversight
Confirm who evaluates eligibility, prescribes medication, monitors side effects, and handles follow-up questions.
Medication sourcing
Ask whether the clinic uses FDA-approved products, how prescriptions are filled, and how compounded products are discussed.
Monitoring plan
Look for structured follow-up around tolerability, nutrition, medication changes, and long-term maintenance.
Nutrition support
Compare how clinics address protein intake, strength training, muscle preservation, hydration, and sustainable habits.
Pricing clarity
Clarify appointment fees, medication costs, insurance billing, cash-pay rates, refill policies, and cancellation terms.
Access model
Ask which services are telehealth-friendly and which require in-person care, labs, or local clinical support.
Provider comparison
Compare GLP-1 Providers
Provider links use current SpanScout GLP-1 / Weight Loss listings.
GLP-1 Providers
94
Offer Telehealth
1
Provider Types
4
Services Compared
13
| Provider | Location | Type | Telehealth | Key services | Profile action |
|---|---|---|---|---|---|
| Flow Wellness SpanScout listing | Seattle, WA | Weight Loss Clinic | Not listed | glp1semaglutideweight loss | |
| 10Rx Health SpanScout listing | Houston, TX | Weight Loss Clinic | Not listed | glp1weight losssemaglutide | |
| 1Stop Clinic SpanScout listing | Houston, TX | Weight Loss Clinic | Not listed | glp1weight losswellness | |
| 61Five Health & Wellness SpanScout listing | Nashville, TN | Weight Loss Clinic | Not listed | glp1semaglutideweight loss | |
| Advitam SpanScout listing | New York, NY | Weight Loss Clinic | Not listed | glp1weight losslongevity | |
| Age Well ATL SpanScout listing | Atlanta, GA | Weight Loss Clinic | Not listed | glp1weight losslongevity | |
| Allure Medical SpanScout listing | Charlotte, NC | Weight Loss Clinic | Not listed | glp1semaglutideweight loss | |
| Art Medica SpanScout listing | Chicago, IL | Multi-Service Clinic | Not listed | glp1semaglutideweight loss |
Next step
Ready to compare GLP-1 providers?
Use SpanScout to browse GLP-1 and medically supervised weight-loss providers, compare services, and visit provider profiles.
Find GLP-1 ProvidersFAQ
Questions before booking
What is GLP-1 therapy?
GLP-1 therapy refers to treatment with medications that act on GLP-1 pathways involved in blood sugar regulation, appetite, and digestion. Specific products have different approved uses and safety information.
Are all GLP-1 medications approved for weight loss?
No. Some products are approved for type 2 diabetes, some for chronic weight management, and some have additional specific indications. Product names, doses, and labels matter.
What side effects should I ask about?
Ask about gastrointestinal side effects, low blood sugar risk when combined with certain diabetes medications, gallbladder issues, pancreatitis symptoms, kidney concerns from dehydration, allergic reactions, and product-specific warnings.
Can GLP-1 treatment be managed through telehealth?
Some clinics use telehealth for eligibility review, follow-up, and side-effect discussions. Labs, exams, pharmacy coordination, or urgent symptoms may still require in-person care.
Continue Exploring
Sources and disclaimer
Medical references used for this guide
Prescription Medications to Treat Overweight & Obesity
National Institute of Diabetes and Digestive and Kidney Diseases
Used for weight-management medication eligibility concepts, lifestyle context, product distinctions, and long-term treatment considerations.
FDA Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
U.S. Food and Drug Administration
Used for compounded semaglutide and tirzepatide cautions, dosing-error concerns, and distinctions from FDA-approved products.
WEGOVY prescribing information
DailyMed / U.S. National Library of Medicine
Used for semaglutide weight-management indications, product-specific warnings, contraindications, and administration-form context.
ZEPBOUND prescribing information
DailyMed / U.S. National Library of Medicine
Used for tirzepatide weight-management indications, GIP/GLP-1 mechanism, limitations of use, warnings, and contraindications.
Obesity and Weight Management: Standards of Care in Diabetes - 2026
American Diabetes Association
Used for diabetes and obesity pharmacotherapy context, benefit-risk framing, long-term therapy considerations, and individualized dosing/tolerability concepts.
This guide is for education and provider discovery only. It does not diagnose obesity, diabetes, or any other condition, and it does not recommend a medication or dose. Talk with a qualified healthcare professional about eligibility, contraindications, product selection, monitoring, side effects, costs, and alternatives.
Trust signal
Why trust SpanScout?
SpanScout helps readers compare providers using visible listing data and provider attributes. Claimed or featured status may help identify enhanced listings, but paid placement does not replace independent comparison of services, credentials, access, and fit.
Providers cannot pay for higher placement in comparison results.